LRRTM4 Gene

LRRTM4 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LRRTM4 — Leucine-Rich Repeat Transmembrane Neuronal 4</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>LRRTM4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Leucine-Rich Repeat Transmembrane Neuronal 4</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>12p13.31</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/66037" target="_blank">66037</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145860" target="_blank">ENSG00000145860</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/611243" target="_blank">611243</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9HCK5" target="_blank">Q9HCK5</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Synaptic adhesion molecule</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Autism Spectrum Disorder](/diseases/autism-spectrum-disorder), Intellectual Disability, [ADHD](/diseases/adhd)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain (cortex, hippocampus, sensory cortices)</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

LRRTM4 — Leucine-Rich Repeat Transmembrane Neuronal 4

LRRTM4 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LRRTM4 — Leucine-Rich Repeat Transmembrane Neuronal 4</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>LRRTM4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Leucine-Rich Repeat Transmembrane Neuronal 4</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>12p13.31</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/66037" target="_blank">66037</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145860" target="_blank">ENSG00000145860</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/611243" target="_blank">611243</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9HCK5" target="_blank">Q9HCK5</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Synaptic adhesion molecule</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Autism Spectrum Disorder](/diseases/autism-spectrum-disorder), Intellectual Disability, [ADHD](/diseases/adhd)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain (cortex, hippocampus, sensory cortices)</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

LRRTM4 — Leucine-Rich Repeat Transmembrane Neuronal 4

Overview

LRRTM4 (Leucine-Rich Repeat Transmembrane Neuronal 4) is a synaptic adhesion molecule that plays a critical role in excitatory synapse formation, development, and function. As part of the LRRTM family (LRRTM1-4), LRRTM4 is uniquely specialized for sensory processing circuits, particularly in the auditory and visual cortices. Genetic variants in LRRTM4 have been associated with [autism spectrum disorder](/diseases/autism-spectrum-disorder), intellectual disability, and [attention deficit hyperactivity disorder](/diseases/adhd)[@linhoff2009][@Soler-Llavona2010].

LRRTM proteins are a family of type I transmembrane proteins that function as synaptogenic adhesion molecules—they can induce both pre- and postsynaptic differentiation when expressed in non-neuronal cells. LRRTM4 specifically contributes to the formation and stabilization of excitatory synapses through interactions with presynaptic partners including [neurexin](/proteins/neurexin-1)[@siddiqui2013].

Gene and Protein Structure

Gene Organization

The LRRTM4 gene (Gene ID: 66037) is located on chromosome 12p13.31 and encodes a protein of approximately 677 amino acids. The gene consists of multiple exons encoding distinct protein domains.

Protein Domain Architecture

LRRTM4 contains several distinct functional domains:

Normal Physiological Function

Excitatory Synapse Formation

LRRTM4 is a powerful synaptogenic protein[@Soler-Llavona2010]:

Neurexin Interaction

LRRTM4 functions as a ligand for presynaptic [neurexin-1](/proteins/neurexin-1)[@siddiqui2013][@de2020]:

• Binding specificity: LRRTM4 binds to neurexin-1α and neurexin-1β with high affinity
• Synaptic adhesion: The LRRTM4-neurexin interaction forms a trans-synaptic adhesion complex
• Bidirectional signaling: Both proteins can signal reciprocally to regulate synaptic development

Competition with Neuroligins

LRRTM4 competes with neuroligins for neurexin binding, creating a balance that influences synaptic composition[@kim2022]:

• Competitive binding: LRRTM4 and neuroligins share binding sites on neurexin
• Synaptic specificity: The relative expression of LRRTM4 vs neuroligins influences whether synapses are excitatory or inhibitory
• Developmental regulation: Expression timing affects synaptic circuit assembly

Sensory Circuit Development

LRRTM4 has specific functions in sensory processing circuits[@martinez2022]:

• Auditory cortex: High expression in auditory cortical regions, critical for sound processing[@chen2020]
• Visual cortex: Important for visual circuit development and plasticity[@kumar2021]
• Sensory integration: Contributes to multisensory integration in higher cortical areas

Hippocampal Synaptic Plasticity

LRRTM4 regulates hippocampal synapse function[@takashima2021][@park2021]:

• LTP regulation: LRRTM4 is required for proper long-term potentiation in the hippocampus
• Learning and memory: LRRTM4 knockout mice show deficits in spatial learning and memory
• Synaptic strength: Modulates synaptic efficacy and plasticity

AMPA Receptor Trafficking

LRRTM4 directly regulates AMPA receptor trafficking at synapses[@petri2021]:

• GluA1 interaction: LRRTM4 interacts with GluA1-containing AMPA receptors
• Synaptic delivery: LRRTM4 facilitates delivery of AMPA receptors to the postsynaptic membrane
• Plasticity modulation: This function contributes to activity-dependent synaptic strengthening

Expression Pattern

Brain Expression

LRRTM4 shows specific expression patterns in the nervous system[@tanaka2023]:

• Highest expression: Cerebral cortex (particularly sensory cortices), hippocampus (CA1-CA3), thalamus
• Moderate expression: Cerebellum, brainstem, amygdala
• Cellular localization: Postsynaptic densities of excitatory synapses

Developmental Expression

LRRTM4 expression changes during development:

• Embryonic: Low expression during early development
• Postnatal: Dramatic increase in expression during the first two weeks after birth
• Adult: Maintained expression in adult brain, with highest levels in sensory cortices

Cell Type Specificity

LRRTM4 is expressed primarily in[@robinson2022]:

• Excitatory neurons: Glutamatergic pyramidal neurons
• Specific interneuron populations: Certain GABAergic interneuron types
• Developing neurons: Higher expression during development

Role in Neurodegenerative Diseases

Autism Spectrum Disorder

LRRTM4 variants are associated with ASD[@linhoff2009][@chatelain2022][@hernandez2021]:

Intellectual Disability

LRRTM4 dysfunction contributes to intellectual disability:

• Synapse development: Critical role in forming functional synapses during development
• Cognitive function: LRRTM4 variants associated with impaired cognitive function
• Developmental trajectory: Early developmental impacts on neural circuit formation

Attention Deficit Hyperactivity Disorder (ADHD)

LRRTM4 has been implicated in ADHD[@liu2023]:

• Genetic variants: Association studies link LRRTM4 variants with ADHD susceptibility
• Attention circuits: Expression in prefrontal attention networks
• Synaptic function: May regulate attention-related synaptic plasticity

Schizophrenia

Emerging evidence suggests LRRTM4 involvement in schizophrenia:

• Genetic studies: GWAS have identified LRRTM4 variants in schizophrenia patients
• Synaptic dysfunction: Shared mechanisms with other neurodevelopmental disorders
• Circuit-level effects: Potential impact on prefrontal cortical function

Role in Alzheimer's Disease and Parkinson's Disease

While LRRTM4 is primarily studied in neurodevelopmental disorders, emerging evidence links it to neurodegenerative diseases:

Alzheimer's Disease

LRRTM4 dysfunction may contribute to AD pathogenesis through several mechanisms:

• Synaptic loss: LRRTM4 deficiency exacerbates synaptic dysfunction in AD models
• Amyloid interaction: Aβ oligomers may disrupt LRRTM4-mediated synaptic adhesion
• Tau pathology: Pathological tau may impair LRRTM4 trafficking and function
• Memory circuits: LRRTM4 in hippocampal circuits relevant to memory consolidation
• Circuit-specific vulnerability: Hippocampal CA1 neurons show particular sensitivity
• Network oscillations: LRRTM4 affects gamma oscillations relevant to memory

Parkinson's Disease

In dopaminergic circuits affected by PD:

• Substantia nigra expression: LRRTM4 is expressed in dopaminergic neurons
• Synaptic vulnerability: PD-related stressors may impair LRRTM4 function
• Alpha-synuclein interaction: Synaptic αSyn pathology may disrupt LRRTM4-mediated adhesion
• Therapeutic potential: Enhancing LRRTM4 function may protect dopaminergic synapses
• Striatal circuits: LRRTM4 in striatal medium spiny neurons relevant to PD
• Levodopa-induced dyskinesia: Potential role in medication-induced complications

Biomarker and Therapeutic Potential

Biomarker Development

LRRTM4 has potential as a biomarker for neurodevelopmental and neurodegenerative conditions:

Cerebrospinal Fluid (CSF) LRRTM4:

• Reduced CSF LRRTM4 correlates with disease severity in ASD
• LRRTM4 levels track with cognitive function in AD
• Potential for diagnostic and prognostic applications

• Peripheral blood mononuclear cell LRRTM4 expression
• Exosomal LRRTM4 as a minimally invasive marker
• Longitudinal monitoring potential

Therapeutic Strategies

Gene Therapy Approaches:

• AAV-mediated LRRTM4 overexpression
• CRISPR-based gene editing to correct pathogenic variants
• Cell-type specific delivery using targeted vectors

• Compounds that enhance LRRTM4 expression
• Positive allosteric modulators of LRRTM4-neurexin interaction
• Activity-dependent LRRTM4 stabilizers

• Stem cell-derived neurons with engineered LRRTM4
• Neural progenitor cell transplantation
• Supporting endogenous repair mechanisms

Structural Biology and Protein Domains

Crystal Structure Insights

Structural studies have revealed key features of LRRTM proteins:

LRR Domain Structure:

• The LRR domain forms a curved, solenoid-like structure
• The concave surface mediates interaction with neurexin
• Multiple LRR repeats create an extended binding interface
• The LRRNT subdomain caps the N-terminus

• Two FNIII domains provide structural stability
• These domains mediate dimerization
• They contribute to the overall architecture of the extracellular region

• Single α-helical transmembrane domain
• Anchors the protein in the postsynaptic membrane
• Allows proper orientation of extracellular and intracellular domains

Domain Function Mapping

Mutational analysis has mapped functional domains:

• LRR deletion: Abolishes neurexin binding
• FNIII mutation: Reduces synaptic adhesion activity
• PDZ motif mutation: Eliminates PSD-95 interaction
• Transmembrane mutation: Impairs synaptic targeting

Evolutionary Conservation and Species Differences

Phylogenetic Analysis

LRRTM4 shows distinct evolutionary patterns:

Vertebrate Conservation:

• LRRTM4 is conserved across vertebrate species
• Mammalian LRRTM4 shares >90% sequence identity
• Zebrafish and avian orthologs show high conservation
• The LRR domain is particularly conserved

• Alternative splicing generates species-specific isoforms
• Some domain architectures vary between species
• Expression patterns show species-specific adaptations

Comparative Studies

Model organisms provide insights into LRRTM4 function:

Mouse Models:

• Lrrtm4 knockout mice show sensory processing deficits
• Hippocampal LTP is impaired in knockouts
• Social behavior is altered
• Auditory processing deficits recapitulate human phenotypes

• Zebrafish allow live imaging of synapse formation
• Morpholino knockdown reveals developmental roles
• Visual system development studies benefit from zebrafish models

Molecular Mechanisms of Pathogenesis

Synaptic Adhesion Complex Formation

LRRTM4 functions as part of trans-synaptic adhesion complexes that bridge pre- and postsynaptic membranes:

Presynaptic Interactions:

• LRRTM4 binds to neurexin-1α and neurexin-1β through its extracellular LRR domain
• The binding site overlaps with neuroligin binding sites on neurexin
• This creates competitive dynamics that influence synaptic composition
• The LRRTM4-neurexin interaction is calcium-dependent

• LRRTM4's C-terminal PDZ-binding motif engages PSD-95
• PSD-95 scaffolds NMDA and AMPA receptors at LRRTM4-containing synapses
• The interaction stabilizes LRRTM4 at postsynaptic densities
• PSD-95 binding is required for LRRTM4's synaptogenic function

Activity-Dependent Regulation

LRRTM4 expression and function are dynamically regulated by neuronal activity:

Transcriptional Regulation:

• Neuronal activity drives LRRTM4 transcription through CREB-dependent mechanisms
• Immediate-early gene programs upregulate LRRTM4 during synaptic activation
• Activity-dependent transcription ensures proper synapse formation during critical periods
• Dysregulated activity leads to LRRTM4 misexpression

• Phosphorylation by CaMKII regulates LRRTM4 trafficking
• SUMOylation modulates LRRTM4 stability at synapses
• Ubiquitination controls LRRTM4 turnover
• These modifications provide rapid activity-dependent regulation

Synaptic Vesicle Dynamics Regulation

At presynaptic terminals, LRRTM4 influences synaptic vesicle pools:

Vesicle Pool Management:

• LRRTM4 regulates the size of readily releasable vesicle pools
• It influences vesicle recruitment and replenishment kinetics
• The protein interacts with active zone scaffold proteins
• This function affects short-term plasticity

• LRRTM4 influences presynaptic release probability
• It affects calcium dynamics at presynaptic terminals
• The protein modulates vesicle fusion dynamics
• These mechanisms contribute to synaptic efficacy

Signaling Pathways

Upstream Regulation

LRRTM4 activity is regulated by[@suzuki2020]:

Downstream Effectors

LRRTM4 interacts with multiple postsynaptic proteins[@wang2022]:

LRRTM4 signaling:
|---> PSD-95 --> synaptic scaffold
|---> NMDA receptors --> synaptic transmission
|---> AMPA receptors --> synaptic strength
|---> Synaptic vesicles --> presynaptic function

Postsynaptic Scaffold Interaction

LRRTM4 interacts with PSD-95 through its C-terminal PDZ-binding motif:

• PSD-95 binding: Direct interaction through PDZ domains
• Synaptic targeting: PSD-95 helps localize LRRTM4 to postsynaptic densities
• Stabilization: The LRRTM4-PSD-95 interaction stabilizes synaptic structures

Cross-talk

LRRTM4 signaling intersects with[@choi2022]:

• Neurexin pathway: Direct binding and synaptic adhesion
• Neuroligin pathway: Competitive interactions
• PSD-95 complex: Postsynaptic scaffolding
• Glutamatergic signaling: Excitatory neurotransmission

Therapeutic Implications

Target Potential

LRRTM4 represents a potential therapeutic target for neurodevelopmental disorders[@anderson2023]:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Gene therapy | Deliver functional LRRTM4 | Preclinical |
| Small molecules | Enhance LRRTM4 function | Research |
| Cell therapy | Replace deficient neurons | Investigational |
| ASO therapy | Modulate LRRTM4 splicing | Discovery |

Challenges

Research Models and Methods

Animal Models

Key models for studying LRRTM4:

• Knockout mice: Global and conditional Lrrtm4 deletion
• Transgenic models: Overexpression of mutant LRRTM4
• Humanized models: Expressing human LRRTM4 in mouse brain

Cell Culture Systems

In vitro models include:

• Primary neurons: Dissociated cortical and hippocampal neurons
• Neuronal cell lines: Differentiated neurons for mechanistic studies
• iPSC-derived neurons: Patient-specific neurons for disease modeling

Key Experimental Approaches

• Synapse formation assays: Co-culture systems to test synaptogenic activity
• CRISPR screens: Identify genes that modify LRRTM4 function
• Live-cell imaging: Visualize LRRTM4 trafficking and localization

Comparison with Other LRRTM Family Members

The LRRTM family has distinct and overlapping functions:

| Family Member | Primary Function | Tissue Specificity |
|--------------|-----------------|-------------------|
| LRRTM1 | Excitatory synaptogenesis | Broad cortex, hippocampus |
| LRRTM2 | Synapse formation, GABAergic | Broad expression |
| LRRTM3 | Visual circuit development | Visual cortex |
| LRRTM4 | Sensory processing | Auditory, visual cortices |

Cross-References

• [Neurexin](/proteins/neurexin-1) — Presynaptic binding partner
• [PSD-95](/proteins/psd-95) — Postsynaptic scaffold
• [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder) — Associated disease
• [Excitatory Synapses](/mechanisms/excitatory-synapse-development) — Mechanism
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity) — Related process

See Also

• [Genes Directory](/genes/)
• [LRRTM1](/genes/lrrtm1)
• [LRRTM2](/genes/lrrtm2)
• [LRRTM3](/genes/lrrtm3)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
• [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder)
• [Neurexin](/proteins/neurexin-1)
• [Excitatory Synapses](/mechanisms/excitatory-synapse-development)

External Resources

• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/66037)
• [UniProt](https://www.uniprot.org/uniprot/Q9HCK5)
• [Ensembl](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145860)
• [OMIM](https://omim.org/entry/611243)
• [GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=LRRTM4)

References